AJP - Renal Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 296: F170-F176, 2009. First published November 5, 2008; doi:10.1152/ajprenal.90487.2008
0363-6127/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/1/F170    most recent
90487.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matavelli, L. C.
Right arrow Articles by Majid, D. S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matavelli, L. C.
Right arrow Articles by Majid, D. S. A.

Renal hemodynamic and excretory responses to intra-arterial infusion of peroxynitrite in anesthetized rats

Luis C. Matavelli,1 Philip J. Kadowitz,2 L. Gabriel Navar,1 and Dewan S. A. Majid1

Departments of 1Physiology and 2Pharmacology, Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, New Orleans, Louisiana

Submitted 13 August 2008 ; accepted in final form 3 November 2008

Peroxynitrite (ONOO) is formed endogenously by the reaction of nitric oxide (NO) and superoxide (O2). To examine the hypothesis that OONO cause renal vasodilation at low concentrations but cause vasoconstriction at higher concentrations, we examined renal responses to intra-arterial infusion of incremental doses of OONO (10, 20, and 40 µg·kg–1·min–1; 45 min each) in anesthetized rats. Renal blood flow (RBF) and glomerular filtration rate (GFR) were determined by PAH and inulin clearance. In control rats (n = 6), low dose (10 µg·kg–1·min–1) of OONO increased RBF by 10 ± 3% and GFR by 15 ± 5%. The higher doses (20 and 40 µg·kg–1·min–1) mostly reversed these responses which were –7 ± 4 and –27 ± 7% (P < 0.05) in RBF and –0.1 ± 4.8 and –14 ± 12% in GFR, respectively. There were no appreciable changes in urine flow (V) and sodium excretion (UNaV) during OONO infusion. However, in rats pretreated with NO synthase (NOS) inhibitor, L-NAME (50 µg·kg–1·min–1; n = 5), these doses of ONOO significantly reduced RBF (–26 ± 7, –27 ± 6, and –44 ± 3%) and GFR (–21 ± 6, –25 ± 8, and –32 ± 12%) with variable increases in V or UNaV. Long-term infusion of OONO (10 µg·kg–1·min–1 for 75 min) in another set of control rats (n = 5) also showed similar vasodilator and hyperfiltration responses. These data indicate that ONOO acts as an oxidant at high concentration but provides renoprotective function at low concentration that depends on intact NOS activity.

nitric oxide; superoxide; oxidative stress; renal blood flow; glomerular filtration rate



Address for reprint requests and other correspondence: D. S. A. Majid, Dept. of Physiology, Tulane Univ. Health Sciences Center, 1430 Tulane Ave., SL 39, New Orleans, LA 70112 (e-mail: majid{at}tulane.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.